Core Viewpoint - The company, Sdiq, has reported a significant increase in sales revenue for 2024, driven by substantial growth in its optical display, new energy, and PET film segments, with a projected revenue growth target for the next three years [1][2][3]. Group 1: Sales Revenue Growth - In 2024, Sdiq's sales revenue is expected to grow by 37%, with the optical display, new energy, and PET film segments showing substantial increases [1][2]. - The projected sales revenue for 2025, 2026, and 2027 is set to increase by 40%, 75%, and 120% respectively, translating to revenue targets of 3.767 billion, 4.709 billion, and 5.920 billion yuan [3][4]. Group 2: Drivers of Revenue Growth - The anticipated revenue growth is attributed to the completion of large-scale expansion projects, ongoing development of new products and customers, and the trend of domestic substitution for "bottleneck" materials [1][4][5]. - Sdiq has significantly increased its long-term asset investments, growing from 1 billion yuan to 5.1 billion yuan over five years, which supports its revenue growth trajectory [4]. Group 3: Segment Performance - The optical display segment is highlighted as the most promising area, with high R&D investment and value-added products, particularly in the foldable screen and VR glasses markets [5]. - In 2024, the optical display segment achieved a revenue increase of 114%, while the PET film segment saw a remarkable growth of 158% [2]. Group 4: Profitability Challenges - Despite the revenue increase, Sdiq experienced a situation of revenue growth without profit growth in 2024 due to rising depreciation, labor, R&D, and financial costs [1][6]. - Key expense categories saw significant increases, including depreciation rising by 49% and R&D expenses increasing by 41%, primarily due to the transition of major projects from construction to operational phases [6][7].

斯迪克：光学显示板块进口替代进程有加速的预期 金十数据5月20日讯， 斯迪克近日在接受机构调研时表示，光学显示板块是公司研发投入最大、产品附 加值最高的业务板块，该领域的市场很大，长期以来美国和日本的供应商占领了绝大多数的市场份额。 近年来，斯迪克在折叠屏和VR眼镜领域，已经积累了一定的经验，光学显示板块的销售收入呈现快速 增长的态势。全球关税风暴之后，该领域进口替代的进程有加速的预期。 ...

Group 1: Sales Revenue Breakdown - In 2024, the sales revenue by business segment showed significant growth, with total revenue increasing by 37% from 2023 to 2024, amounting to 269,055 million CNY [2][4] - The breakdown of sales revenue for 2024 is as follows: - Optical Display: 55,159 million CNY (114% increase) - New Energy: 47,108 million CNY (61% increase) - Microelectronics: 11,222 million CNY (24% increase) - Civil Adhesive Tape: 47,030 million CNY (16% increase) - PET Film: 14,080 million CNY (158% increase) - Other Functional Adhesives: 94,457 million CNY (9% increase) [2][4] Group 2: Future Revenue Expectations - The company has set ambitious sales revenue targets for the next three years based on the 2024 revenue, with the following growth percentages: - 2025: 40% increase (37.67 billion CNY) - 2026: 75% increase (47.09 billion CNY) - 2027: 120% increase (59.20 billion CNY) [3] Group 3: Growth Drivers - Key factors contributing to the expected revenue growth include: - Completion of large-scale expansion projects, allowing for increased sales capacity [4] - Continuous development of new products and clients, enhancing the company's ability to serve major manufacturers [4] - The trend of domestic substitution for "bottleneck" materials in the current international landscape [4] Group 4: Profitability Challenges - Despite a 37% increase in sales revenue in 2024, the company faced a situation of revenue growth without profit growth due to rising costs: - Depreciation increased by 49% to 37,218 million CNY - Labor costs rose by 22% to 37,516 million CNY - R&D expenses increased by 41% to 12,610 million CNY - Financial costs surged by 47% to 10,643 million CNY [6][7][8] - The total increase in major expenses was 36%, amounting to 97,988 million CNY in 2024 [7][8]

Core Viewpoint - The company is focused on expanding its AI image recognition technology applications in various medical testing fields, aiming to become a comprehensive service provider in medical laboratory equipment and related products [2][3]. Company Development and Technology - The company has diversified its product line in the medical testing instrument sector and is applying its core technology to blood, body fluid, pathology, and microbiological testing [2]. - The company has established a competitive advantage in the automation of clinical specimen microscopic examination, having entered this technology field early and developed a leading medical microscopic image database [4][5]. Industry Outlook - The high-end medical device industry is expected to have broad development prospects driven by national import substitution policies, technological innovation, and globalization strategies [3]. - The integration of artificial intelligence technology with modern diagnostic medicine is anticipated to accelerate the shift towards intelligent diagnostics in various fields [12]. Financial Performance - In 2024, the company achieved a net profit of 22.84 million yuan, a year-on-year increase of 6.07%, with a significant increase in net profit excluding non-recurring gains of 24.99% [10]. - For Q1 2025, the company reported a net profit of 6.32 million yuan, up 24.63% year-on-year, and a net profit of 5.01 million yuan after excluding non-recurring gains, reflecting a 48.77% increase [10][13]. Market Strategy - The company plans to maintain continuous R&D investment and product updates to sustain its competitive edge in the industry [8]. - Future growth drivers include expanding into new customer segments, particularly in grassroots and civilian markets, as well as international markets [8]. Product Applications - The company is leveraging machine vision and deep learning technologies to automate the analysis of microscopic components in clinical specimens, significantly improving accuracy and efficiency [5]. - The company is also exploring applications of its technology in non-medical fields such as aquatic biological detection and mineral testing [9].

Group 1: Market Overview - The company's downstream clients are traditionally concentrated in the petrochemical, metallurgy, and energy industries, but there has been a rapid growth in the renewable energy, new materials, and environmental protection sectors recently [2][3] - The high-end control valve market is highly competitive, with foreign brands holding approximately 60%-70% market share, while domestic brands, including the company, occupy about 30%-40% [3] Group 2: Order and Performance - The company currently has a sufficient order backlog, with stable order acquisition in the first half of the year [3] - The company achieved operating revenue of 1,093.09 million yuan and a net profit attributable to shareholders of 22.70 million yuan in 2024 [3] Group 3: Growth Strategies - The company plans to maintain stable growth by enhancing product technology and optimizing after-sales service while deeply exploring market demands [3] - The company is increasing R&D investment and collaborating with universities and research institutions to develop new product categories and create new market opportunities [3] - The company aims to leverage capital market platforms to explore industrial development opportunities while strengthening its core business [3]

[Table_Title] 研究报告 Research Report 19 May 2025 [Table_header2] 奇德新材 (300995 CH) APPENDIX 1 Summary 奇德新材 Guangdong Kitech New Material (300995 CH) 高分子复合改性材料领军企业，碳纤维制品发展空间广阔 Polymer composite modified materials leader, accelerating international layout 孙小涵 Xiaohan Sun xh.sun@htisec.com [Table_yemei1] 热点速评 Flash Analysis [Table_summary] (Please see APPENDIX 1 for English summary) [Table_yejiao1] 本研究报告由海通国际分销，海通国际是由海通国际研究有限公司，海通证券印度私人有限公司，海通国际株式会社和海通国 际证券集团其他各成员单位的证券研究团队所组成的全球品牌，海通国际证券集团各成员分别在其许可的司法管辖区内从事证 券活动。 ...

Investment Rating - The report maintains a "Buy" rating for several companies including Xinyangfeng, Senqilin, Ruifeng New Materials, Sinopec, and others [10]. Core Viewpoints - The report highlights significant price increases in products such as butadiene (up 21.98%) and styrene (up 12.11%), while products like liquid chlorine and p-nitrochlorobenzene saw notable declines [4][18]. - It suggests focusing on investment opportunities in import substitution, domestic demand, and high-dividend assets due to the current international oil price stabilization and geopolitical uncertainties [6][19]. - The report emphasizes the mixed performance across different sub-sectors within the chemical industry, with some sectors like tires and lubricants showing better-than-expected results [21]. Summary by Sections Industry Tracking - International oil prices have stabilized, with WTI at $61.62 per barrel and Brent at $64.53, reflecting a 2.85% and 2.69% increase respectively [6][22]. - The downstream demand has shown a noticeable decline, particularly in the propane market, which has seen a price drop of 1.43% [25]. - The coking coal market has experienced a price decline of 1.87% due to limited steel demand and expectations of reduced production [26]. Price Movements - Significant price increases were noted in butadiene, styrene, and hydrochloric acid, while liquid gas and natural gas prices fell [4][18]. - The PTA market saw a rise, with prices increasing by 6.74% in the East China market, driven by strong demand and rising costs [30]. Key Companies and Profit Forecasts - Companies such as Xinyangfeng, Senqilin, and Sinopec are highlighted for their strong earnings per share (EPS) growth and favorable price-to-earnings (PE) ratios, making them attractive investment options [10]. - The report suggests that companies in the tire industry, such as Senqilin and Sailun Tire, are well-positioned to benefit from global trade dynamics and tariff exemptions [21]. Investment Opportunities - The report recommends focusing on sectors that can benefit from import substitution, such as lubricating oil additives and special coatings, as well as domestic fertilizer production which is less affected by tariffs [21][8]. - It also highlights the potential of high-dividend stocks in the oil sector, particularly Sinopec, PetroChina, and CNOOC, as attractive investment options in the current market environment [6][21].

Group 1: Sales Revenue Breakdown - In 2024, the sales revenue for the optical display segment is projected to increase by 114%, reaching ¥55,159,000 [2] - The renewable energy segment is expected to grow by 61%, with revenue of ¥47,108,000 [2] - The PET film segment shows a significant increase of 158%, with projected revenue of ¥14,080,000 [2] - Overall, the total sales revenue is anticipated to rise by 37%, reaching ¥269,055,000 in 2024 [2] Group 2: Future Revenue Expectations - The company has set ambitious sales revenue targets for the next three years, starting with a 40% increase in 2025, aiming for ¥37.67 billion [3] - The target for 2026 is a 75% increase, reaching ¥47.09 billion [3] - By 2027, the goal is to achieve a 120% increase, totaling ¥59.20 billion [3] Group 3: Growth Drivers - The company has completed major expansion projects, allowing sales revenue to enter a growth phase [4] - Continuous development of new products and clients has strengthened the company's market position [4] - The trend of domestic substitution for "bottleneck" materials is expected to create new opportunities for growth [4] Group 4: Profitability Challenges - Despite a 37% increase in sales revenue in 2024, costs such as depreciation, labor, and R&D expenses have risen significantly [6] - Depreciation expenses increased by 49%, reaching ¥37,218,000 [7] - Labor costs rose by 22%, totaling ¥37,516,000 [7] - R&D expenses (excluding labor and depreciation) increased by 41%, amounting to ¥12,610,000 [7] - Overall, total expenses grew by 36%, reaching ¥97,988,000 [7] Group 5: Cost Structure Insights - Major cost increases are attributed to the transition of construction projects to operational status, leading to higher depreciation [8] - Significant investments in R&D and technology have driven up labor costs and R&D expenses [8] - Financial costs have risen due to the capitalization of borrowing costs transitioning to expenses as projects move into operation [8] - As sales scale increases, fixed costs are expected to be diluted, leading to improved economies of scale [8]

Investment Rating - The report assigns a "Buy" rating to the company, indicating a potential upside in the stock price [5][8]. Core Views - The company has shown strong performance in the first quarter of 2025, with revenue and net profit both recording double-digit growth despite a backdrop of declining global storage product prices. This performance is attributed to the company's position as a leader in the domestic storage sector and its expected benefits from the recovery of the semiconductor demand [5][8]. - The report anticipates a recovery in the storage and MCU (Microcontroller Unit) industries starting from the second quarter of 2025, which is expected to accelerate the company's earnings growth [5][8]. Summary by Sections Company Overview - The company operates in the electronics industry, with a stock price of 122.29 RMB as of May 16, 2025. The market capitalization is approximately 81.17 billion RMB, and the major shareholder is Zhu Yiming, holding 6.89% of shares [3]. Financial Performance - In Q1 2025, the company achieved revenue of 1.91 billion RMB, a year-over-year increase of 17.3%, and a net profit of 230 million RMB, reflecting a 14.5% increase year-over-year. The performance is notable given the overall decline in global storage market prices [8]. - The report projects net profits for 2025, 2026, and 2027 to be 1.58 billion RMB, 2.11 billion RMB, and 2.71 billion RMB, respectively, with year-over-year growth rates of 43%, 34%, and 28% [7][8]. Market Outlook - The global storage market is expected to see price increases starting in Q2 2025, driven by AI demand and capacity control by storage manufacturers. The company is positioned to benefit from this trend as a leading supplier of Nor Flash and niche DRAM products [8]. - The MCU industry is also expected to recover, with the company being the largest supplier of 32-bit MCUs in China, which is projected to experience rapid growth starting in 2025 [8]. Valuation Metrics - The current stock price corresponds to a PE ratio of 30 times for 2027, indicating a favorable valuation for potential investors [5][8].

Investment Rating - The report assigns a "Buy" rating to the company, indicating a potential upside in the stock price [5][8]. Core Views - The company has shown strong performance in the first quarter of 2025, with revenue and net profit both recording double-digit growth despite a backdrop of declining global storage product prices. This performance is attributed to the company's position as a leader in the domestic storage sector and its expected benefits from the recovery in the semiconductor demand [5][8]. - The report anticipates a continued recovery in the storage and MCU (Microcontroller Unit) industries starting from the second quarter of 2025, which is expected to accelerate the company's earnings growth [5][8]. Summary by Sections Company Overview - The company operates in the electronics industry, with a stock price of 122.29 RMB as of May 16, 2025. The stock has a 12-month high of 147.56 RMB and a low of 64.13 RMB. The total market capitalization is approximately 81.17 billion RMB [3]. Financial Performance - In Q1 2025, the company achieved revenue of 1.91 billion RMB, representing a year-over-year increase of 17.3% and a quarter-over-quarter increase of 11.9%. The net profit for the same period was 230 million RMB, with a year-over-year growth of 14.5% [8]. - The report projects net profits for 2025, 2026, and 2027 to be 1.58 billion RMB, 2.11 billion RMB, and 2.71 billion RMB, respectively, with year-over-year growth rates of 43%, 34%, and 28% [8]. Market Position and Outlook - The company is positioned as a leading player in the domestic storage market, benefiting from domestic import substitution and increasing semiconductor demand. The report highlights that the company is expected to maintain significant earnings elasticity as the industry recovers [5][8]. - The anticipated recovery in global storage prices due to AI demand and capacity control by manufacturers is expected to positively impact the company's performance [8]. Valuation Metrics - The current stock price corresponds to a price-to-earnings (P/E) ratio of 30 times for 2027, with projected P/E ratios of 52 times for 2024 and 39 times for 2025 [8].